KaNDy Therapeutics presents new compelling data with lead candidate NT-814 at The North American Menopause Society 2018 Annual Meeting

~ Treatment with NT-814 resulted in immediate improvements in bothersome post-menopausal symptoms~ ~ Phase Ib/IIa data showed rapid and significant reductions in the frequency and severity of hot [...]

Contact Us

Please fill out the form to get in touch with us.

Not readable? Change text. captcha txt